Boston Technology Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Boston Technology Review.

Press releases published on October 27, 2026

Oct. 27, 2026

Pasqal’s Neutral-Atom Processor Uncovers Quantum Magnet Behavior That Theory Did Not Predict

Indeterminate GlobeNewswire

Oct. 27, 2026

WISeSat.Space and Kaynes Space Technology Advance Partnership to Develop Post-Quantum Security for Indian Satellites

Indeterminate GlobeNewswire

Oct. 27, 2026

Microchip Achieves Key Program Milestones for its PIC64-HPSC Spaceflight Computing Series

Indeterminate GlobeNewswire

Oct. 27, 2026

TrueCommerce Strengthens Leadership Team with New CFO and EMEA Managing Director as It Accelerates Its AI-Driven Supply Chain Network Strategy

Indeterminate GlobeNewswire

Oct. 27, 2026

TrueCommerce Strengthens Leadership Team with New CFO and EMEA Managing Director as It Accelerates Its AI-Driven Supply Chain Network Strategy

Indeterminate GlobeNewswire

Oct. 27, 2026

TrueCommerce Strengthens Leadership with New CFO and Managing Director for EMEA as Company Accelerates Its AI-Driven Supply Chain Network Strategy

Indeterminate GlobeNewswire

Oct. 27, 2026

vTv Therapeutics Announces First Participant Randomized in Phase 2a Pilot Study Evaluating Cadisegliatin in Individuals with Type 1 Diabetes (T1D) Using Hybrid Closed-Loop (HCL) Insulin Delivery Systems

Indeterminate GlobeNewswire

Oct. 27, 2026

Legend Biotech to Host Investor Conference Call on Third Quarter 2026 Results

Indeterminate GlobeNewswire

Oct. 27, 2026

Madrigal to Present Multiple Abstracts at AASLD's The Liver Meeting 2026, Including New Real-World Evidence Reinforcing Rezdiffra as a Foundational Therapy for MASH

Indeterminate GlobeNewswire

Oct. 27, 2026

AssistRx Named a Central Florida Top Workplace for Sixth Consecutive Year

Indeterminate GlobeNewswire

Oct. 27, 2026

NeuroOne Featured in New York Post on OneRF® Patient’s Remarkable Journey to Overcome Debilitating Facial Pain

Indeterminate GlobeNewswire

Oct. 27, 2026

Inhibikase Therapeutics Announces Participation in Upcoming Investor Conferences During November 2026

Indeterminate GlobeNewswire

Oct. 27, 2026

red violet Climbs 25 Spots to No. 82 on TIME’s America’s Growth Leaders of 2027 List

Indeterminate GlobeNewswire

Oct. 27, 2026

Entera Appoints Global Research and Development Leader Dr. Juan Camilo Arjona Ferreira to Its Board of Directors

Indeterminate GlobeNewswire

Oct. 27, 2026

CAMP4 Therapeutics Receives Clinical Trial Application Approval for Phase 1/2 Clinical Trial of CMP-002 in Patients with SYNGAP1-Related Disorder in the European Union

Indeterminate GlobeNewswire

Oct. 27, 2026

CareCloud Appoints Mitchell Brie as Chief Compliance Officer to Support Compliance Services Growth

Indeterminate GlobeNewswire

Oct. 27, 2026

Calidi Biotherapeutics Presented New CLD-401 Data and In Situ TCE Platform Advances at the ESMO Congress 2026, Including Highlighting the Potential of its RedTail Gene Medicine Platform to Turn Tumors into Localized TCE Biofactories

Indeterminate GlobeNewswire

Oct. 27, 2026

Altimmune Appoints Peter Greenleaf and Alex Howarth, Two Leading Biotech Executives, to Board of Directors to Support Its Strategic Evolution

Indeterminate GlobeNewswire

Oct. 27, 2026

Humanitas Global Health Announces Launch and LSU DeepDrug License Agreement at AAPS PharmSci 360

Indeterminate GlobeNewswire

Oct. 27, 2026

OPKO Health’s OPKO Biologics Doses First Participant in Phase 1/2a Trial of OPK-8801001 for Acromegaly

Indeterminate GlobeNewswire